Answers are grounded in this paper and cite their sources.
Oxidative stress is a common pathophysiological basis for various chronic diseases, including Parkinson's disease, cardiovascular disease, diabetic retinopathy and cancer. Due to its high sensitivity to redox status, DJ‑1 (PARK7) is regarded as a key intracellular oxidative stress sensor. The present review systematically summarized the role of DJ‑1 in related diseases, focusing on its molecular structure and antioxidant mechanisms. DJ‑1 directly scavenges reactive oxygen species through oxidation modification of Cys106, activates the nuclear factor erythroid 2‑related factor 2 (Nrf2)/antioxidant response element transcriptional network, stabilizes mitochondrial complex I, promotes PTEN‑induced putative kinase 1/Parkin‑mediated mitophagy and acts as a molecular chaperone to prevent abnormal protein aggregation, forming a multi‑layered cytoprotective system. DJ‑1 exhibits marked tissue‑protective effects in Parkinson's disease, myocardial ischemia‑reperfusion injury and diabetic retinopathy. DJ‑1 is aberrantly overexpressed in various malignant tumors and promotes cancer cell survival, metastasis and drug resistance by activating the PI3K/AKT and Nrf2 pathways and inhibiting ferroptosis. Furthermore, the function of DJ‑1 in systemic inflammation revealed model‑dependent contradictions, suggesting that its function is finely controlled in different cell types and pathological stages. In summary, DJ‑1 possesses both tissue‑protective and tumor‑promoting functions and intervention strategies targeting DJ‑1 require differential design of activation or inhibition based on the disease context. How the oxidation modification of Cys106 in DJ‑1 selectively modulates downstream signaling pathways remains a key scientific question to be resolved.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: